Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Valacyclovir hydrochloride

Valacyclovir hydrochloride

pharmaceutical raw materials
Valacyclovir hydrochloride structure

Valacyclovir hydrochloride 

structure
  • CAS No:

    124832-27-5

  • Formula:

    C13H20N6O4.ClH

  • Chemical Name:

    Valacyclovir hydrochloride

  • Synonyms:

    L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester,hydrochloride (1:1);L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester,monohydrochloride;BW 256U87;256U87 hydrochloride;Valacyclovir hydrochloride;Valaciclovir hydrochloride;Valtrex;256U;BW 256;Zelitrex;2-[(2-Amino-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate hydrochloride;136489-37-7

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

White Crystalline PowderValacyclovir hydrochloride, an orally active L-valyl ester of the potent antiviral agent aciclovir, was launched in 1995 in the United Kingdom for the treatment of herpes simplex virus (HSV) infections of the skin and mucous membranes, including initial and recurrent genital herpes. As a prodrug, valaciclovir has an improved pharmacokinetic profile to aciclovir. It is rapidly absorbed after oral administration and extensively converted to aciclovir via first-pass metabol


Valacyclovir hydrochloride is an organic molecular entity.|Valacyclovir Hydrochloride is the hydrochloride salt of valacyclovir. Valacyclovir is an acyclovir prodrug that, after metabolization, inhibits viral DNA replication. It is used in the management of herpes simplex and varicella zoster infections, as well as prophylactically for human cytomegalovirus infections.|A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES.

Valacyclovir hydrochloride Basic Attributes

360.8

360.131287

1308068-626-2

G447S0T1VC

759101

DTXSID2044210

C29535

29335990

Characteristics

147

1.28590

white

1.55g/cm3

170-172°C

588.4°C at 760 mmHg

309.7ºC

1.673

H2O: >20mg/mL

Refrigerator

7.95E-14mmHg at 25°C

166 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

3077

3

36/37/38-22

26-36-24/25

Xi,Xn

P301 + P312 + P330

H302

|Warning|H302 (92.65%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 69 companies from 7 notifications to the ECHA C&L Inventory.

Drug Information

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)

2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinate

Valacyclovir hydrochloride Use and Manufacturing

Methods of Manufacturing

To a 1L capacity hydrogenator charged a compound of formula II (50g), concentrated hydrochloric acid (9.6ml), 5percent palladium on carbon (5g) and water (350ml) and hydrogenate the reaction mass under hydrogen pressure of 3 kg/cm 2 to 8 kg/cm 2 at a temperature of 25-30°C for 6 to 12 hours. The reaction mass was filtered under vacuum and washed with water. The filtrate was then distilled off under vacuum. The reaction mass was then cooled and isopropyl alcohol was added to the reaction mass. The reaction mass was further cooled to a temperature of 5-10°C and maintained for 1 hour. The product valacyclovir hydrochloride obtained was filtered and washed with isopropyl alcohol.Yield 92percent and purity 99.8percentANALYTICAL METHOD FOR ANALYSISHPLC column : USP LI, 4.6 x 150 mm, 3.5 ???(Zorbax SB-C18, Part No. 863953-914)Detector : UV 250nmMobile phase A : In a 1000ml volumetric flask add 2.8ml of triethylamine, 800ml of purified water and adjust the pH to 5.00 + 0.05 with glacial acetic acid. Complete the volume with purified water.Mobile Phase B AcetonitrileInjection volume 50??, Column temperature 30°CFlow rate l.OmL/minutesGradientTo a 1L capacity hydrogenator charged a compound of formula II (50 g), concentrated hydrochloric acid (9.6 ml), 5percent palladium on carbon (5 g) and water (350 ml) and hydrogenate the reaction mass under hydrogen pressure of 3 kg/cmPreparation of Solution-A Boc-L-Valacyclovir crude (50 g) was charged into mixture of methylene chloride (375 ml) and methanol (125 ml) at 25-30°C and stirred the reaction mass at 25- 30°C to get the clear solution-A. Preparation of Solution-B Cone. Hydrochloric acid (56 ml) was added to DM water (224 ml) over a period of 15-20 min at 20-25°C. Thereafter methanol (56 ml) was added slowly to the obtained solution at 20-25°C. Above separately prepared solution-A (Flow rate-8 ml/min) and solution-B (Flow rate-5.5 ml/min) were fed to the continuous flow micro reactor at 80°C. The elute reaction mass from micro reactor was continuously collected at 0-5°C. As the feed solutions A & B are consumed micro reactor is flush with methylene chloride (50 ml: 50 ml) each feed. Immediately after the collection of reaction mass, aqueous layer and lower organic layers were separated. The pH of the aqueous layer containing product was adjusted to about 2.5 to 2.8 with triethyl amine (~ 46.28 g) at 0-5 °C). Ethanol (300 ml) at 0-5°C was added slowly to the solution. The obtained reaction mass was distilled under reduced pressure (400-40 mm Hg) to get white. The obtained solid mass was cooled at 25-30°C and ethanol (300 ml) was added and continued stirring the above slurry mass at 25-30°C for 60-80 min. The solid was filtered and washed with chill ethanol (100 ml. 0-5°C). The obtained solid is dried in vacuum dryer at 40-45°C till moisture content is 5-8percent. Yield: 31 g Purity: 99percent (by HPLC)

Uses

Valaciclovir hydrochloride is an antiviral drug used in the management of herpes simplex, herpes zoster, and herpes B.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:360.80
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:8
Exact Mass:360.1312809
Monoisotopic Mass:360.1312809
Topological Polar Surface Area:147
Heavy Atom Count:24
Complexity:483
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

After phosphorylation to form the triphosphate form, it can inhibit the synthesis of herpes virus DNA. The first step of phosphorylation requires the activity of virus-specific enzymes, and further phosphorylation is completed by cellular kinases. The triphosphate form completely inhibits viral DNA polymerase and infiltrates into the DNA chain, causing mandatory chain termination, interrupting DNA synthesis, and thus preventing viral replication.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • JUBILANT BIOSYS LTD

    United States United States
    Active
  • PIRAMAL PHARMA LTD

    United States United States
    Active
  • FLAMMA SPA

    United States United States
    Active

Recommended Suppliers of Valacyclovir hydrochloride

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.